IDVOther than small business
FSS (multiple-award IDV) 36F79720D0081ACROTECH BIOPHARMA INC.
Overview
Award facts
- Orders under this IDV
- No orders recorded under this IDV.
- Period of performance
- From Feb 15, 2020
- Modifications
- 25
- Latest action Jan 7, 2026
- Contract type
- FSS (multiple-award IDV)
- PIID 36F79720D0081
Description of requirement
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Dates and value
- Award date
- Signed on Feb 10, 2020
- Ordering period ends
- Feb 14, 2027
- Ceiling
- Shared program ceiling (all awardees of this multiple-award vehicle, not a per-awardee value): $225,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 7, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationEAST WINDSOR, NJ
UEIDN63NKTYLF33
CAGE code8AH83
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyACROTECH BIOPHARMA INC.
Business types and certifications
Foreign-ownedFor-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Veterans Affairs
- NAC FEDERAL SUPPLY SCHEDULE (36F797)
- Funded by
- Department of Veterans Affairs
- NAC FEDERAL SUPPLY SCHEDULE (36F797)
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Fixed price with economic price adjustmentK
Solicitation and notices
- Solicitation ID
- MS-QS0A-03-R8(as reported)
- Solicitation date
- Dec 17, 2019
Contract details
- Subcontracting plan
- Commercial subcontract planG
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
Transaction history
Modification history
- Base award
- Feb 10, 2020
- Latest action
- Jan 7, 2026 — Supplemental agreement (within scope)Modification P00025
- Latest substantive action
- Jan 7, 2026 — Supplemental agreement (within scope)Modification P00025
- Actions by type
- Base award1
- Supplemental agreement (within scope)20
- Other administrative action5
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business incorporated in the U.S.C
Structure
- Award or IDV
- IDV
- IDV type
- FSSC
- Multiple or single award
- Multiple awardM
- Awarding agency code
- 3600
- Awarding sub-tier code
- 3600
- Contracting office code
- 36F797
- Transactions recorded under this award key
- 26
Funding
- Funding agency code
- 3600
- Funding sub-tier code
- 3600
- Funding office code
- 36F797